A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD

Clinical trial NCT02547935 · COMPLETED

Trial details

NCT number: NCT02547935
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus, CKD and Albuminuria

Start date: 2015-09-21
Primary completion: 2018-05-18
Enrollment: 459

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.